Clinical trials
Active, not recruiting Stomach Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Monopar Therapeutics | 2 |
| ALX Oncology Inc. | 1 |
| Amgen | 1 |
| Arcus Biosciences, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| BeiGene | 1 |
| BioNTech Cell & Gene Therapies GmbH | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Colorectal Neoplasms | 9 |
| Ovarian Neoplasms | 9 |
| Esophageal Neoplasms | 7 |
| Endometrial Neoplasms | 6 |
| Pancreatic Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Carcinoma, Renal Cell | 5 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.